Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
32,001,168
-
Share change
-
+1,190,685
-
Total reported value
-
$911,746,058
-
Price per share
-
$28.49
-
Number of holders
-
189
-
Value change
-
+$33,467,439
-
Number of buys
-
90
-
Number of sells
-
77
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q3 2015
As of 30 Sep 2015,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,001,168 shares.
The largest 10 holders included
Bank of New York Mellon Corp, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Fund Advisors, Broadfin Capital, LLC, STATE STREET CORP, GLENMEDE TRUST CO NA, BlackRock Institutional Trust Company, N.A., LOOMIS SAYLES & CO L P, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
189
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.